Not applicableStudy completedNCT02236897What this trial is testingPET Imaging in ALS PatientsWho this might be right forAmyotrophic Lateral Sclerosis (ALS) Johns Hopkins University 36
Early research (Phase 1)Study completedNCT00538798What this trial is testingPET Imaging of Brain mGluR5 Receptors Using [18F]SP203Who this might be right forHealthyGlutamate ReceptormGlur5 Protein+3 more National Institute of Mental Health (NIMH) 50
Early research (Phase 1)Study completedNCT01896843What this trial is testingEvaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in BrainWho this might be right formGluR5 Receptors National Institute of Mental Health (NIMH) 19
Early research (Phase 1)Study completedNCT00686504What this trial is testingPositron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066Who this might be right forHealthy AstraZeneca 6
Not applicableEnded earlyNCT00951314What this trial is testingBrain Glutamate Receptors and Cocaine DependenceWho this might be right forDrug AbuseCocaine Dependence National Institute on Drug Abuse (NIDA) 30
Early research (Phase 1)Study completedNCT00892944What this trial is testingAn Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516Who this might be right forHealthy AstraZeneca 6
Not applicableUnknownNCT05340660What this trial is testingMGluR5 Imaging in ALS Using PETWho this might be right forAmyotrophic Lateral Sclerosis Nathalie Braun 30
Early research (Phase 1)Study completedNCT06273540What this trial is testingPhase1, STP7 Cocaine Drug-Drug Interaction StudyWho this might be right forCocaine Use Disorder Stalicla SA 21
Post-approval studies (Phase 4)Looking for participantsNCT07076342What this trial is testingThe Role of mGluR5 in CBT-IWho this might be right forMajor Depressive Disorder (MDD) Stony Brook University 42
Early research (Phase 1)UnknownNCT06309147What this trial is testingAssess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson'sWho this might be right forParkinson Disease Allyx Therapeutics 18